| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |